BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16313350)

  • 1. Immune responses and bone loss: the estrogen connection.
    Carlsten H
    Immunol Rev; 2005 Dec; 208():194-206. PubMed ID: 16313350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Jochems C; Islander U; Kallkopf A; Lagerquist M; Ohlsson C; Carlsten H
    Arthritis Rheum; 2007 Oct; 56(10):3261-70. PubMed ID: 17907171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
    Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
    Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens in rheumatoid arthritis; the immune system and bone.
    Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H
    Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T lymphocytes in bone metabolism.
    Weitzmann MN; Pacifici R
    Immunol Rev; 2005 Dec; 208():154-68. PubMed ID: 16313347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30.
    Engdahl C; Jochems C; Windahl SH; Börjesson AE; Ohlsson C; Carlsten H; Lagerquist MK
    Arthritis Rheum; 2010 Feb; 62(2):524-33. PubMed ID: 20112355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review.
    Gennari L; Merlotti D; De Paola V; Calabrò A; Becherini L; Martini G; Nuti R
    Am J Epidemiol; 2005 Feb; 161(4):307-20. PubMed ID: 15692074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
    Ohnaka K; Takayanagi R
    Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone and calcium metabolism in patients with rheumatoid arthritis].
    Furuya T
    Clin Calcium; 2011 Sep; 21(9):1369-75. PubMed ID: 21881200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus.
    Holroyd CR; Edwards CJ
    Climacteric; 2009 Oct; 12(5):378-86. PubMed ID: 19591008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the immune system in the pathophysiology of osteoporosis.
    Clowes JA; Riggs BL; Khosla S
    Immunol Rev; 2005 Dec; 208():207-27. PubMed ID: 16313351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex.
    Andersson A; Bernardi AI; Nurkkala-Karlsson M; Stubelius A; Grahnemo L; Ohlsson C; Carlsten H; Islander U
    Endocrinology; 2016 Mar; 157(3):1013-20. PubMed ID: 26745543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
    Hall JM; McDonnell DP
    Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
    Horner KC
    Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.